Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
about
Systems-level antimicrobial drug and drug synergy discovery.Overcoming resistance to β-lactam antibiotics.A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidaseOxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus.The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential.A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase.Prospects for new antibiotics: a molecule-centered perspective.Genomic tools to profile antibiotic mode of action.Yeast: a microbe with macro-implications to antimicrobial drug discovery.Natural products as a source of drug leads to overcome drug resistance.Strategies for target identification of antimicrobial natural products.In vitro activity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D β-lactamase-producing Acinetobacter baumannii.Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.Bacterial proteases, untapped antimicrobial drug targets.Harnessing the power of transposon mutagenesis for antibacterial target identification and evaluation.Staphylococcus aureus type I signal peptidase: essential or not essential, that's the question.Tetracyclic indolines as a novel class of β-lactam-selective resistance-modifying agent for MRSA.Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA.Actinomycetes: still a source of novel antibiotics.Stable Signal Peptides and the Response to Secretion Stress in Staphylococcus aureus.Scalable Access to Arylomycins via C-H Functionalization Logic.Tetracycline-Inactivating Enzymes.
P2860
Q34626969-545288C6-D636-4ADC-BFE1-F0D79B7B572FQ34636678-BCAA5375-10E1-4F2A-9015-F9809BAAAB28Q35607659-BB083908-FC08-48E8-A31E-61F35588A3B6Q35746200-4EF50A7E-D544-43E7-A6BC-4DFBEA33CD19Q35839071-F80370C4-FB46-470B-A98C-D254F86C4FE7Q35973012-3648EA76-5363-488C-9A52-8630E3EE601CQ36208442-9CC4F080-9701-46EB-820D-31C390DFCBDFQ37236298-BD5B1F2B-A163-414D-96AD-46430413E7BEQ38113689-907421B9-1B90-4473-AA1B-57F32DBF759EQ38195069-5E9AB74A-DED4-499A-B5B6-7353635A66CAQ38601083-2F19AA70-1105-4118-BFE8-BCC51FB70798Q38620371-ACB8805B-122F-4A6D-9FD3-0FC27ED5DC30Q38710256-47BF1EC5-4415-43FD-B27B-DB672F14F762Q38945089-24E905AE-7225-4734-B256-067558BA9979Q38987844-B05D8A93-89FC-491B-ABC4-EC138CA56DBDQ39023951-A7A2ACAC-F861-41FA-B5F1-3AA614870E96Q39531375-3967E3FA-29C8-447B-AF41-D57809D35A1EQ40240598-FCF825B5-6B71-4E59-940E-C480C5A6EB15Q40530965-093341D8-E421-4916-B3EF-C911D6F91E90Q41094756-A5471947-1DD4-428E-B3CF-9D63E35044E0Q46319269-B262479B-DD8F-41BD-B513-D12E28435772Q46899542-D4A5E276-BB41-4464-9AB3-A192A1B9826AQ48142209-6995A7A1-4F53-41A7-B2E6-C93D54A070F3Q55082798-398CBD40-03F1-4995-AC08-3AB361D1869A
P2860
Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@ast
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@en
type
label
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@ast
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@en
prefLabel
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@ast
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@en
P2093
P2860
P356
P1476
Broadening the spectrum of β-l ...... on of signal peptidase type I.
@en
P2093
Aimie M Ogawa
Alex G Therien
Alexandre Caron
Andrew M Galgoci
Anna A Michels
Christian Lebeau-Jacob
Christopher M Tan
Craig A Parish
David Claveau
Joann L Huber
P2860
P304
P356
10.1128/AAC.00726-12
P407
P577
2012-06-18T00:00:00Z